Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 234

1.

Effect of CCR5-delta32 heterozygosity on the risk of perinatal HIV-1 infection: a meta-analysis.

Contopoulos-Ioannidis DG, O'Brien TR, Goedert JJ, Rosenberg PS, Ioannidis JP.

J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):70-6. Erratum in: J Acquir Immune Defic Syndr. 2003 Apr 15;32(5):575.

PMID:
12514416
2.

CCR5 genotype and HIV-1 infection in perinatally-exposed infants.

Mas A, Español T, Heredia A, Pedraza MA, Hernandez M, Caragol I, Fernando M, Bertran JM, Alcami J, Soriano V.

J Infect. 1999 Jan;38(1):9-11.

PMID:
10090498
3.

Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis.

Ioannidis JP, Contopoulos-Ioannidis DG, Rosenberg PS, Goedert JJ, De Rossi A, Espanol T, Frenkel L, Mayaux MJ, Newell ML, Pahwa SG, Rousseau C, Scarlatti G, Sei S, Sen L, O'Brien TR; HIV Host Genetics International Meta-Analysis Group.

AIDS. 2003 Jul 25;17(11):1631-8.

PMID:
12853745
4.

Co-receptor usage of HIV-1 primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission.

Ometto L, Zanchetta M, Mainardi M, De Salvo GL, Garcia-Rodriguez MC, Gray L, Newell ML, Chieco-Bianchi L, De Rossi A.

AIDS. 2000 Aug 18;14(12):1721-9.

PMID:
10985308
5.

Genetic variations in CC chemokine receptors and hypertension.

Zhang M, Ardlie K, Wacholder S, Welch R, Chanock S, O'Brien TR.

Am J Hypertens. 2006 Jan;19(1):67-72.

PMID:
16461193
6.

Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection.

Marmor M, Sheppard HW, Donnell D, Bozeman S, Celum C, Buchbinder S, Koblin B, Seage GR 3rd; HIV Network for Prevention Trials Vaccine Preparedness Protocol Team.

J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):472-81.

PMID:
11511825
7.

Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.

Mulherin SA, O'Brien TR, Ioannidis JP, Goedert JJ, Buchbinder SP, Coutinho RA, Jamieson BD, Meyer L, Michael NL, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Theodorou ID, Vlahov D, Rosenberg PS; International Meta-Analysis of HIV Host Genetics.

AIDS. 2003 Feb 14;17(3):377-87.

PMID:
12556692
8.

Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.

Ioannidis JP, Rosenberg PS, Goedert JJ, Ashton LJ, Benfield TL, Buchbinder SP, Coutinho RA, Eugen-Olsen J, Gallart T, Katzenstein TL, Kostrikis LG, Kuipers H, Louie LG, Mallal SA, Margolick JB, Martinez OP, Meyer L, Michael NL, Operskalski E, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Stewart GJ, Theodorou ID, Ullum H, Vicenzi E, Vlahov D, Wilkinson D, Workman C, Zagury JF, O'Brien TR; International Meta-Analysis of HIV Host Genetics.

Ann Intern Med. 2001 Nov 6;135(9):782-95.

PMID:
11694103
9.

Phenotypic expressions of CCR5-delta32/delta32 homozygosity.

Nguyêñ GT, Carrington M, Beeler JA, Dean M, Aledort LM, Blatt PM, Cohen AR, DiMichele D, Eyster ME, Kessler CM, Konkle B, Leissinger C, Luban N, O'Brien SJ, Goedert JJ, O'Brien TR.

J Acquir Immune Defic Syndr. 1999 Sep 1;22(1):75-82.

PMID:
10534150
10.

Risk of mother-to-infant transmission of HIV-1 is not reduced in CCR5/delta32ccr5 heterozygotes.

Edelstein RE, Arcuino LA, Hughes JP, Melvin AJ, Mohan KM, King PD, McLellan CL, Murante BL, Kassman BP, Frenkel LM.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 1;16(4):243-6.

PMID:
9402070
11.

CCR5 promoter polymorphisms and HIV-1 perinatal transmission in Brazilian children.

de Souza PR, Arraes LC, de Lima Filho JL, Bruneska D, Milanese M, Crovella S.

J Reprod Immunol. 2006 Feb;69(1):77-84. Epub 2005 Oct 17.

PMID:
16233918
12.

CCR5 genotype and resistance to vertical transmission of HIV-1.

Philpott S, Burger H, Charbonneau T, Grimson R, Vermund SH, Visosky A, Nachman S, Kovacs A, Tropper P, Frey H, Weiser B.

J Acquir Immune Defic Syndr. 1999 Jul 1;21(3):189-93.

PMID:
10421241
13.

32-nucleotide deletion, associated with defence against hiv/aids, is a predominant mutation of CCR5 gene in the population of Georgia.

Kamkamidze G, Capoulade-Metay C, Butsashvili M, Dudoit Y, Chubinishvili O, Debre P, Theodorou L.

Georgian Med News. 2005 Jan;(118):74-9.

PMID:
15821335
14.

Effect of CCR5-Δ32 heterozygosity on HIV-1 susceptibility: a meta-analysis.

Liu S, Kong C, Wu J, Ying H, Zhu H.

PLoS One. 2012;7(4):e35020. doi: 10.1371/journal.pone.0035020. Epub 2012 Apr 4.

15.

Protective effect of CCR2-64I and not of CCR5-delta32 and SDF1-3'A in pediatric HIV-1 infection.

Mangano A, Kopka J, Batalla M, Bologna R, Sen L.

J Acquir Immune Defic Syndr. 2000 Jan 1;23(1):52-7.

PMID:
10708056
16.

Protective effect of CCR5 delta 32 heterozygosity is restricted by SDF-1 genotype in children with HIV-1 infection.

Sei S, Boler AM, Nguyen GT, Stewart SK, Yang QE, Edgerly M, Wood LV, Brouwers P, Venzon DJ.

AIDS. 2001 Jul 27;15(11):1343-52.

PMID:
11504955
17.

CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status.

Hoffman TL, MacGregor RR, Burger H, Mick R, Doms RW, Collman RG.

J Infect Dis. 1997 Oct;176(4):1093-6.

PMID:
9333175
18.

Effect of chemokine receptor mutations on heterosexual human immunodeficiency virus transmission.

Lockett SF, Alonso A, Wyld R, Martin MP, Robertson JR, Gore SM, Leen CL, Brettle RP, Yirrell DL, Carrington M, Brown AJ.

J Infect Dis. 1999 Sep;180(3):614-21.

PMID:
10438347
19.

Population survey of CCR5 delta32, CCR5 m303, CCR2b 64I, and SDF1 3'A allele frequencies in indigenous Chinese healthy individuals, and in HIV-1-infected and HIV-1-uninfected individuals in HIV-1 risk groups.

Wang FS, Hong WG, Cao Y, Liu MX, Jin L, Hu LP, Wang Z, Feng TJ, Hou J, Zhang B, Shi M, Xu DP, Lei ZY, Wang B, Liu ZD, Ye JJ, Peng L, Qiu Y, Winkler C.

J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):124-30.

PMID:
12571520
20.

CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual.

Oh DY, Jessen H, Kücherer C, Neumann K, Oh N, Poggensee G, Bartmeyer B, Jessen A, Pruss A, Schumann RR, Hamouda O.

PLoS One. 2008 Jul 23;3(7):e2747. doi: 10.1371/journal.pone.0002747.

Supplemental Content

Support Center